(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futatsubashi, M; Ouchi, Y; Torizuka, T; Yagi, S; Yokokura, M; Yoshihara, Y; Yoshikawa, E | 1 |
| Bergman, J; Haaparanta, M; Kaasinen, V; Nurmi, E; Rinne, JO; Ruottinen, HM; Solin, O | 1 |
2 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Disease Exacerbation
| Article | Year |
|---|---|
Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET.
Topics: Adult; Aged; Cerebral Cortex; Cocaine; Disease Progression; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis | 2010 |
Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
Topics: Aged; Antiparkinson Agents; Brain; Carrier Proteins; Caudate Nucleus; Cerebellum; Cocaine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Fluorine Radioisotopes; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Putamen; Time Factors; Tomography, Emission-Computed | 2000 |